4.7 Article

Biological effects of hexitol and altritol-modified siRNAs targeting B-Raf

Journal

EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 606, Issue 1-3, Pages 38-44

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.ejphar.2009.01.030

Keywords

siRNA; Hexitol; Altritol; Chemical modification; B-Raf; Stability

Funding

  1. NIH [PO1 GM59299]

Ask authors/readers for more resources

increasing the effectiveness of siRNAs through chemical modification is an important task. Here we describe altritol and hexitol modified oligonucleotides targeting the B-Raf oncogene that is critical for the growth and survival of melanoma cells. Using assays for apoptosis, DNA synthesis, colony formation and B-Raf protein and message levels, we demonstrate that certain hexitol modifications can improve the effectiveness of B-Raf siRNAs and also increase duration of action. Altritol modified siRNAs were similar to or slightly less effective than unmodified B-Raf siRNA. Modifications at the 3' or 5' end of the sense strand, at the 3' end of the antisense strand, or within either strand were well tolerated. The basis for the increased effectiveness of the hexitol-modified siRNAs is not fully understood but may be partly due to increased stability to nucleases. (C) 2009 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available